Unum Group (UNM) Buyback Puts Focus On Whether Shares Still Look Undervalued

Unum Group buyback announcement and why it matters for shareholders

Unum Group (UNM) has announced a new share repurchase program, with Board approval on 26 August 2026 to buy back up to US$1.0b of its outstanding common stock.

This authorization gives Unum Group flexibility to return additional capital to shareholders over time. Investors often watch such buyback plans closely because they can affect earnings per share and the stock’s supply in the market.

Unum Group’s buyback news arrives after a period of solid momentum, with a 7 day share price return of 6.02% and a 30 day return of 8.06%, while the 1 year total shareholder return of 36.41% and 5 year total shareholder return of 309.74% point to strong longer term gains.

Scan how Unum Group’s buyback news compares to other insurers returning capital to shareholders by reviewing our curated list of 12 dividend fortresses.

Unum Group’s buyback and strong recent returns can signal either a business that is quietly doing the heavy lifting or sentiment that has run ahead of reality. Which story does the current valuation suggest?

Most Popular Narrative: 9% Undervalued

The most followed narrative values Unum Group at $102.23 a share, compared with the latest close at $93.05. That gap rests on some specific long term assumptions about growth, profitability and buybacks.

Strategic derisking of the legacy long term care (LTC) block through external reinsurance transactions is freeing up capital, reducing earnings volatility, and allowing management to focus on more profitable and capital-efficient core businesses, supporting steadier net income and increased share repurchases.

Read the complete narrative.

Want to see what really underpins that fair value for Unum Group? The narrative leans heavily on a step change in profitability and a shrinking share count. Curious which long term earnings and margin assumptions have to hold to close the gap between $93.05 and $102.23? The full story lays out those numbers in detail.

Result: Fair Value of $102.23 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Unum Group story can change quickly if long term care claims remain challenging or if benefit ratios in key disability and life lines stay elevated.

Find out about the key risks to this Unum Group narrative.

Another view on Unum Group’s value

The first narrative leans on earnings growth and buybacks to argue Unum Group is around 9% undervalued at $102.23 per share. A different lens tells a cooler story. At a P/E of 21x, the stock trades well above the US Insurance industry at 11.3x and a fair ratio of 16.3x, which suggests far less margin for error if growth or capital returns disappoint.

For investors, that gap between the current P/E, the sector, and the fair ratio points to valuation risk if expectations reset, especially after a 36.4% 1 year total shareholder return. The key question is whether Unum Group’s buyback and LTC de risking plans are strong enough to justify that richer multiple or if expectations have moved ahead of fundamentals.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this Unum Group story feels finely balanced between confidence and caution, move quickly to test the numbers yourself and shape your own view with 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Unum Group?

Do not stop with Unum Group. The best opportunities often appear where others are not looking, so give yourself options before committing fresh capital.

• Target companies that combine strong fundamentals with appealing prices using our hand picked 45 high quality undervalued stocks.
• Prioritise financial resilience by working through this focused list of solid balance sheet and fundamentals (52 results).
• Spot potential future leaders early by combing through a carefully filtered 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com